Download Free Sample Report

Ophthalmic Anti-infective Drug Market, Global Outlook and Forecast 2023-2030

Ophthalmic Anti-infective Drug Market, Global Outlook and Forecast 2023-2030

  • Published on : 25 January 2023
  • Pages :63
  • Report Code:SMR-7543420

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
This report contains market size and forecasts of Ophthalmic Anti-infective Drug in Global, including the following market information:
Global Ophthalmic Anti-infective Drug Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Ophthalmic Anti-infective Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Eyedrops Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ophthalmic Anti-infective Drug include Alcon, AbbVie, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Johnson & Johnson and Thea pharmaceuticals, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ophthalmic Anti-infective Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Anti-infective Drug Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Ophthalmic Anti-infective Drug Market Segment Percentages, by Type, 2022 (%)
Eyedrops
Gels
Ointments
Other
Global Ophthalmic Anti-infective Drug Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Ophthalmic Anti-infective Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Others
Global Ophthalmic Anti-infective Drug Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Ophthalmic Anti-infective Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Anti-infective Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ophthalmic Anti-infective Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group